bbT369
CRC-403
Phase 1 mab terminated
Quick answer
bbT369 for Diffuse Large B Cell Lymphoma (DLBCL) is a Phase 1 program (mab) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Diffuse Large B Cell Lymphoma (DLBCL)
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated